Sign in
Taking peopleNo phase

Predicting serious problems in adults with sudden pulmonary embolism using CT scan findings

Studies scan and hospital measures to predict worsening in adults with pulmonary embolism.

Key facts

Who runs it
Shengjing Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Status
Recruiting
People taking part
300 people, planned
Started
18 Jan 2021
Expected to end
31 Dec 2026
Type of study
Observational
Record updated
11 March 2026

Who can take part

The trial is looking for adults with acute pulmonary embolism (a blood clot in the lung arteries) diagnosed by a CT scan of the lung arteries. It studies tests at admission that may predict problems within 30 days.

Age
18 years or older
Sex
All sexes
Disease stage
Acute pulmonary embolism, diagnosed by CT pulmonary angiography (a CT scan of the lung blood vessels)
Earlier treatment
People cannot join if they had reperfusion treatment (treatment to reopen the blocked artery) before admission.
Main reasons for not taking part
  • Pregnancy
  • Reperfusion treatment before admission
  • Missing CT data
  • Missing echocardiography (heart ultrasound) data
  • Missing cardiac troponin I (c-Tn I) or NT-pro BNP blood test levels
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography

Who cannot take part

  • missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels
  • pregnancy
  • reception of reperfusion treatment before admission

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Pulmonary embolism and thrombosis

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.

The group in the trial

  • Acute pulmonary embolism

    an age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using Parameters Obtained by Computed Tomographic Pulmonary Angiography.
Plain-language title
Predicting serious problems in adults with sudden pulmonary embolism using CT scan findingsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT05098769, who can take part
Publications
Record updated
11 March 2026